Hologic, Inc. (NASDAQ: HOLX)

Sector: Medical

Current Price : $58.99

52 Week Low
$16.8052 Week High
$58.99

Charts

Technical Charts

Analyst

Analyst Ratings

Analyst Estimates

Sales Estimates

Ratios

Financial Ratios

Technicals

Press Releases
Quest Diagnostics and Hologic Form Strategic Alliance to Improve Women's Health
First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection
Hologic Receives FDA Approval for a New Low-dose 3D Mammography (Breast Tomosynthesis) Solution for Breast Cancer Screening
Hologic Appoints Scott Garrett to Board of Directors
Benefits of Using Hologic's Breast Tomosynthesis Mammography Technology Supported in Published Italian Study
Hologic Announces Second Quarter Fiscal 2013 Operating Results
Study Published in European Radiology Further Supports the Use of Hologic's Breast Tomosynthesis in Cancer Screening in Practices Using Double Reads
StockCall Early Morning Insight into St. Jude Medical, Hologic, Navidea Biopharma, ResMed, and Edwards Lifesciences
SuperSonic Imagine : SuperSonic Imagine Announces a Significant Financing Round -- 28 Million Euros Raised -- FSI Subscribes to Half the Round Alongside Historical Investors and Two New Arrivals
Hologic to Release Second Quarter Fiscal 2013 Operating Results on Monday, May 6, 2013
Hologic Announces Expiration of 6.25% Senior Notes Exchange Offer
Hologic Completes Sale of LIFECODES to Immucor
Immucor Completes Acquisition of LIFECODES(R) Business from Hologic, Inc.
Hologic's "3D Technology: A More Accurate Mammogram" Mobile Coach Tour Makes Special Stop at National Consortium of Breast Center's Annual Conference in Las Vegas
Hologic Announces Completion of Loan Repricing
Hologic's 3D Mammography Technology to be the "New Standard of Care," According to Healthcare Research Firm KLAS
StockCall Pre-Market Review on Hologic, St. Jude Medical, ResMed, and Navidea Biopharma
3D Mammography Mobile Tour Takes the Latest in Breast Cancer Screening on the Road
Hologic to Showcase Game-Changing Breast Tomosynthesis Technology and Other Product Innovations at the European Congress of Radiology in Vienna
Hologic Announces Launch of 6.25% Senior Notes Exchange Offer
HOLOGIC, INC. ANNOUNCES EXCHANGE TRANSACTION TO RETIRE 2.00% CONVERTIBLE SENIOR NOTES DUE 2037
Today's Research on Hologic and St. Jude Medical: Will Affordable Care Act Ultimately be Beneficial for the Industry?
HOLOGIC TO PRESENT AT FOUR UPCOMING INVESTOR CONFERENCES
Free Research Report on Arch Coal, Inc., Limited Brands, Inc., Western Union Co. (The) and Hologic, Inc.
Hologic Announces First Quarter Fiscal 2013 Operating Results
Hologic to Showcase 3D Mammography and Other Recent Innovations in Healthcare at the 38th Arab Health Congress in Dubai
HOLOGIC ANNOUNCES ORGANIZATIONAL CHANGES TO ITS DIAGNOSTICS SEGMENT; INTEGRATION OF GEN-PROBE PROCEEDING AHEAD OF SCHEDULE
The Oslo Breast Cancer Screening Trial Concludes that the Use of 3D Mammography in Combination with a 2D Breast Exam Finds Significantly More Cancers than a 2D Breast Exam Alone
Hologic Announces FDA Clearance of APTIMA Trichomonas for Use on PANTHER System
The Oslo Breast Cancer Screening Trial Concludes that the Use of 3D Mammography in Combination with a 2D Breast Exam Finds Significantly More Cancers than a 2D Breast Exam Alone
Hologic to Release First Quarter Fiscal 2013 Operating Results on Monday, February 4, 2013
Immucor to Acquire the LIFECODES(R) Business From Hologic, Inc.
Hologic Announces Sale of LIFECODES to Immucor
Should Recent Insider Selling on PCS, GRMN, HOLX and KLIC Matter to You?
Hologic to Showcase Award Winning 3D Mammography and Other Advanced Imaging Technologies at RSNA 2012
Hologic To Present At Two Upcoming Investor Presentations
Hologic to Showcase Advancement Simplifying Removal of Large Intrauterine Pathology at AAGL
Factors of Influence, Economy and Policy - Research & Analysis on Hologic, Inc. and CareFusion Corporation
Technical Analysis on Hologic Inc. and St. Jude Medical Inc. - Medical Appliance & Equipment Makers Evolving
Hologic Announces FDA Approval of APTIMA HPV 16 18/45 Genotype Assay for Use on the TIGRIS System
Hologic Announces Favorable Ruling In Litigation With Becton, Dickinson
Hologic to Host Investor Presentation at RSNA 2012
Hologic to Release Fourth Quarter Fiscal 2012 Operating Results on Monday, November 12, 2012
Where We Are Headed -- New Outlook on Hologic, Inc. and St. Jude Medical, Inc.
Hologic, Inc. [HOLX] Marks Breast Cancer Awareness Month by Ringing the NASDAQ Stock Market Opening Bell
Hologic, Inc. Marks Breast Cancer Awareness Month by Ringing the Opening Bell at NASDAQ and Taking 3D Mammography on the Road
Hologic Announces Verdict In Patent Infringement Suit
Equity Research on Hologic Inc. and St. Jude Medical Inc. - Medical Appliances and Equipment Recalling and Rearranging
Senator Blumenthal, a Strong Advocate for Women's Health, Visits Hologic's Manufacturing Facility in Danbury, CT
Gen-Probe Receives Stockholder Approval For Proposed Merger With Hologic
Analyst Research on Hologic Inc. and Medtronic Inc. - New Products Propelling Medical Equipment Companies
SolarWinds Inc. to Join S&P MidCap 400; HealthStream Inc. to Join the S&P SmallCap 600
Hologic Announces Pricing Of Financing In Connection With Acquisition Of Gen-Probe
Hologic Human Papillomavirus (HPV) High-Risk Test Approved for Use in The Netherlands Population Cervical Screening Programme
Hologic And Gen-Probe Provide Update On Pending Transaction
Hologic, Inc. Announces Note Offering
Hologic Breast Tomosynthesis (3D Mammography) System Places First in KLAS Annual Survey of Mammography Equipment Users
Hologic to Release Third Quarter Fiscal 2012 Operating Results on Monday, July 30, 2012
Today's Market Driven by Key Factors - Featured Research on Hologic, Inc. and Health Management Associates, Inc.
Hologic and Gen-Probe Announce Expiration of Hart-Scott-Rodino Act Waiting Period
Equity Research on Medtronic Inc. and Hologic Inc. - Medical Equippers Focus on International Markets and Acquisitions
Conditions of Growth, Economic Analysis - Research Report on SINA Corporation (USA) and Hologic, Inc.
Hologic to Participate in Four Investor Conferences
Hologic Delivers on Its Promise to Provide Innovative, Minimally Invasive Technologies for Gynecologists and Obstetricians at the ACOG Annual Clinical Meeting
Law Office of Brodsky & Smith, LLC Announces Investigation of Gen-Probe Incorporated
Gen-Probe Incorporated (GPRO) Shareholder Alert: Bernstein Liebhard LLP Announces Investigation of Acquisition by Hologic, Inc.
Buyout Of Gen-Probe - Shareholder Investigation By Tripp Levy PLLC On Behalf Of Gen-Probe Shareholders
Hologic to Acquire Gen-Probe
Hologic CEO Honored at American Cancer Society Key Gala
Hologic to Release Second Quarter Fiscal 2012 Operating Results on Monday, April 30, 2012
Analytical Reports on Hologic Inc. and Medtronic Inc. - Positive Long-Term Outlook for Medical Equipment Makers
WaferGen (WGBS) Names Former Johnson & Johnson (NYSE: JNJ) Manager to CEO Position
WaferGen Appoints Ivan Trifunovich President, CEO, and Director
Hologic, Inc. Announces Exchange Transaction to Retire 2.00% Convertible Senior Notes Due 2037
Hologic to Launch Four New Products at the European Congress of Radiology in Vienna
2012 Economic Outlook -- Report Highlights Hologic, Inc. and Mattel, Inc.
Conditions of Growth, Economic Analysis - Research Report on Hologic, Inc. and SBA Communications Corporation
Hologic to Release First Quarter Fiscal 2012 Operating Results on Monday, January 30, 2012
FDA Approves Hologic's Cervista High Throughput Automation System for Cervical Cancer Screening
Hologic to Present at the Nasdaq OMX 27th Investor Program in London
Hologic Introduces Synthesized 2D Image Algorithm Designed to Eliminate the Need for a 2D Mammogram in a 2D plus 3D Tomosynthesis Exam
Hologic to Showcase 3D Mammography (Breast Tomosynthesis) and Other Advanced Women's Imaging Technologies at RSNA 2011, the Largest Radiology Show in the World
Analytical Reports on Hologic Inc. and Zimmer Holdings Inc. - Medical Appliances & Equipment Releasing New Products
Hologic Showcases Alternatives to Traditional Gynecologic Surgeries at 2011 American Association of Gynecologic Laparoscopists (AAGL) Congress
Hologic Announces Appointment of New Director
Hologic to Host Investor Presentation at RSNA 2011
Genetic Technologies Limited Announces Quarterly Activities Report for the Quarter Ended 30 September 2011
Hologic Adds New Products to Its MRI Solutions Portfolio
Hologic to Host Special Tomosynthesis Symposium and Feature the Latest in Women's Health Technologies at the Journees Francaises de Radiologie (JFR)
FDA Clears Hologic's Specimen Radiography System
Hologic Announces Jury Verdict in Patent Infringement Suit
Hologic Announces Six-year Follow-up Results from the MammoSite Targeted Breast Irradiation Registry Study
Biogen Idec Promotes Tony Kingsley to Run Global Commercial Operations
Hologic Celebrates 10 Years of Providing Women with a Minimally Invasive Solution for Their Heavy Periods
Hologic to Release Fourth Quarter Fiscal 2011 Operating Results on Monday, November 7, 2011
Hologic to Preside Over NASDAQ Opening Bell Ceremony Marking the Start of Breast Cancer Awareness Month
Hologic Launches Automated Cervical Cancer Screening Solutions at IPV Meeting in Berlin
Analyst Research on Hologic Inc. and Zimmer Holdings Inc. - Medical Appliances and Equipment See Growing Sales
Hologic to Release Third Quarter Fiscal 2011 Operating Results on Monday, August 1, 2011
Hologic Breast Tomosynthesis System Wins Top Award in Medical Design Excellence Competition

Two Week FREE Trial

iStock Rating

Hologic, Inc. (NASDAQ: HOLX)

Sector: Medical

Company

Community

Analysis

Charts

Analyst

Ratios